# Particulate Corticosteroid Versus Non-particulate Corticosteroid for Sacroiliac Joint Injection

> **NCT03166761** · PHASE4 · TERMINATED · sponsor: **Vanderbilt University Medical Center** · enrollment: 41 (actual)

## Conditions studied

- Sacro-Iliac Spondylosis

## Interventions

- **DRUG:** Dexamethasone
- **DRUG:** Triamcinolone Acetonide

## Key facts

- **NCT ID:** NCT03166761
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-09-14
- **Primary completion:** 2023-02-28
- **Final completion:** 2023-02-28
- **Target enrollment:** 41 (ACTUAL)
- **Why stopped:** recruitment and staffing
- **Last updated:** 2024-07-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03166761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03166761, "Particulate Corticosteroid Versus Non-particulate Corticosteroid for Sacroiliac Joint Injection". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT03166761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*